Login

Letícia Rodrigues de Souza

ORCID: 0000-0003-1916-813X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5018052292
Research Areas
  • Microscopic Colitis
  • Eosinophilic Esophagitis
  • Inflammatory Bowel Disease

Pontifícia Universidade Católica do Paraná
 2023

 Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study
OPENALEX - Publications 
Letícia Rodrigues de Souza Daniéla Oliveira Magro Fábio Vieira Teixeira Rogério Serafim Parra Eron Fábio Miranda and 7 more Omar Féres Rogério Saad-Hossne Giedre Herrerias Renato Nisihara Cláudio Saddy Rodrigues Coy Lígia Yukie Sassaki Paulo Gustavo Kotze

Despite some variability in ideal serum Adalimumab (ADA) concentrations, there is increasing evidence that higher concentrations of anti-TNF-α agents can be associated with sustained efficacy, and low or undetectable levels may lead to loss response. This study aims correlate ADA clinical endoscopic activity patients Crohn’s disease (CD). A cross-sectional multicentric was performed CD, who used for at least 24 weeks. Patients were allocated into groups according the presence activity. Serum...

10.3390/pharmaceutics15020586 article EN cc-by Pharmaceutics 2023-02-09
Coming Soon ...